# Vitamin E for Oxaliplatin-induced Peripheral Neuropathy Prophylaxis

> **NCT01523574** · PHASE2 · COMPLETED · sponsor: **Felipe Melo Cruz** · enrollment: 38 (actual)

## Conditions studied

- Peripheral Neuropathy

## Interventions

- **DRUG:** Vitamin E
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01523574
- **Lead sponsor:** Felipe Melo Cruz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-11
- **Final completion:** 2010-12
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2012-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01523574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01523574, "Vitamin E for Oxaliplatin-induced Peripheral Neuropathy Prophylaxis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01523574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*